Cargando…

Biochemistry of Bacterial Multidrug Efflux Pumps

Bacterial pathogens that are multi-drug resistant compromise the effectiveness of treatment when they are the causative agents of infectious disease. These multi-drug resistance mechanisms allow bacteria to survive in the presence of clinically useful antimicrobial agents, thus reducing the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sanath, Varela, Manuel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344227/
https://www.ncbi.nlm.nih.gov/pubmed/22605991
http://dx.doi.org/10.3390/ijms13044484
_version_ 1782231944316059648
author Kumar, Sanath
Varela, Manuel F.
author_facet Kumar, Sanath
Varela, Manuel F.
author_sort Kumar, Sanath
collection PubMed
description Bacterial pathogens that are multi-drug resistant compromise the effectiveness of treatment when they are the causative agents of infectious disease. These multi-drug resistance mechanisms allow bacteria to survive in the presence of clinically useful antimicrobial agents, thus reducing the efficacy of chemotherapy towards infectious disease. Importantly, active multi-drug efflux is a major mechanism for bacterial pathogen drug resistance. Therefore, because of their overwhelming presence in bacterial pathogens, these active multi-drug efflux mechanisms remain a major area of intense study, so that ultimately measures may be discovered to inhibit these active multi-drug efflux pumps.
format Online
Article
Text
id pubmed-3344227
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-33442272012-05-17 Biochemistry of Bacterial Multidrug Efflux Pumps Kumar, Sanath Varela, Manuel F. Int J Mol Sci Review Bacterial pathogens that are multi-drug resistant compromise the effectiveness of treatment when they are the causative agents of infectious disease. These multi-drug resistance mechanisms allow bacteria to survive in the presence of clinically useful antimicrobial agents, thus reducing the efficacy of chemotherapy towards infectious disease. Importantly, active multi-drug efflux is a major mechanism for bacterial pathogen drug resistance. Therefore, because of their overwhelming presence in bacterial pathogens, these active multi-drug efflux mechanisms remain a major area of intense study, so that ultimately measures may be discovered to inhibit these active multi-drug efflux pumps. Molecular Diversity Preservation International (MDPI) 2012-04-10 /pmc/articles/PMC3344227/ /pubmed/22605991 http://dx.doi.org/10.3390/ijms13044484 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kumar, Sanath
Varela, Manuel F.
Biochemistry of Bacterial Multidrug Efflux Pumps
title Biochemistry of Bacterial Multidrug Efflux Pumps
title_full Biochemistry of Bacterial Multidrug Efflux Pumps
title_fullStr Biochemistry of Bacterial Multidrug Efflux Pumps
title_full_unstemmed Biochemistry of Bacterial Multidrug Efflux Pumps
title_short Biochemistry of Bacterial Multidrug Efflux Pumps
title_sort biochemistry of bacterial multidrug efflux pumps
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344227/
https://www.ncbi.nlm.nih.gov/pubmed/22605991
http://dx.doi.org/10.3390/ijms13044484
work_keys_str_mv AT kumarsanath biochemistryofbacterialmultidrugeffluxpumps
AT varelamanuelf biochemistryofbacterialmultidrugeffluxpumps